Cargando…
Aurora kinases: novel therapy targets in cancers
Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially the process of chromosomal segregation. Besides regulating mitosis, Aurora kinases have been implicat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410356/ https://www.ncbi.nlm.nih.gov/pubmed/28147341 http://dx.doi.org/10.18632/oncotarget.14893 |
_version_ | 1783232665037570048 |
---|---|
author | Tang, Anqun Gao, Keyu Chu, Laili Zhang, Rui Yang, Jing Zheng, Junnian |
author_facet | Tang, Anqun Gao, Keyu Chu, Laili Zhang, Rui Yang, Jing Zheng, Junnian |
author_sort | Tang, Anqun |
collection | PubMed |
description | Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially the process of chromosomal segregation. Besides regulating mitosis, Aurora kinases have been implicated in regulating meiosis. The deletion of Aurora kinases could lead to failure of cell division and impair the embryonic development. Overexpression or gene amplification of Aurora kinases has been clarified in a number of cancers. And a growing number of studies have demonstrated that inhibition of Aurora kinases could potentiate the effect of chemotherapies. For the past decades, a series of Aurora kinases inhibitors (AKIs) developed effectively repress the progression and growth of many cancers both in vivo and in vitro, suggesting that Aurora kinases could be a novel therapeutic target. In this review, we'll first briefly present the structure, localization and physiological functions of Aurora kinases in mitosis, then describe the oncogenic role of Aurora kinases in tumorigenesis, we shall finally discuss the outcomes of AKIs combination with conventional therapy. |
format | Online Article Text |
id | pubmed-5410356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-54103562017-05-04 Aurora kinases: novel therapy targets in cancers Tang, Anqun Gao, Keyu Chu, Laili Zhang, Rui Yang, Jing Zheng, Junnian Oncotarget Review Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially the process of chromosomal segregation. Besides regulating mitosis, Aurora kinases have been implicated in regulating meiosis. The deletion of Aurora kinases could lead to failure of cell division and impair the embryonic development. Overexpression or gene amplification of Aurora kinases has been clarified in a number of cancers. And a growing number of studies have demonstrated that inhibition of Aurora kinases could potentiate the effect of chemotherapies. For the past decades, a series of Aurora kinases inhibitors (AKIs) developed effectively repress the progression and growth of many cancers both in vivo and in vitro, suggesting that Aurora kinases could be a novel therapeutic target. In this review, we'll first briefly present the structure, localization and physiological functions of Aurora kinases in mitosis, then describe the oncogenic role of Aurora kinases in tumorigenesis, we shall finally discuss the outcomes of AKIs combination with conventional therapy. Impact Journals LLC 2017-01-29 /pmc/articles/PMC5410356/ /pubmed/28147341 http://dx.doi.org/10.18632/oncotarget.14893 Text en Copyright: © 2017 Tang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Review Tang, Anqun Gao, Keyu Chu, Laili Zhang, Rui Yang, Jing Zheng, Junnian Aurora kinases: novel therapy targets in cancers |
title | Aurora kinases: novel therapy targets in cancers |
title_full | Aurora kinases: novel therapy targets in cancers |
title_fullStr | Aurora kinases: novel therapy targets in cancers |
title_full_unstemmed | Aurora kinases: novel therapy targets in cancers |
title_short | Aurora kinases: novel therapy targets in cancers |
title_sort | aurora kinases: novel therapy targets in cancers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410356/ https://www.ncbi.nlm.nih.gov/pubmed/28147341 http://dx.doi.org/10.18632/oncotarget.14893 |
work_keys_str_mv | AT tanganqun aurorakinasesnoveltherapytargetsincancers AT gaokeyu aurorakinasesnoveltherapytargetsincancers AT chulaili aurorakinasesnoveltherapytargetsincancers AT zhangrui aurorakinasesnoveltherapytargetsincancers AT yangjing aurorakinasesnoveltherapytargetsincancers AT zhengjunnian aurorakinasesnoveltherapytargetsincancers |